Skip to main content

Precision Biosciences Inc

DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001357874

In the last 90 days, Precision Biosciences Inc insiders filed 3 open-market purchases and 0 sales; 95 institutions reported holding it in 13F filings for Q2 2026, worth $138.9M in total; no superinvestor holds it.

Q3 2024 vs. Q2 2024

How the institutions holding Precision Biosciences Inc changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of DTIL: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders47151+5
Shares3.16M52.8K3.32M+215.1K (+6.9%)
Value$30.8M$514.2K$29.8M−$448.0K (−1.5%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (8)

Institutions that held Precision Biosciences Inc at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to DTIL in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.55,113$493.8K0.00%
Royal Bank of Canada33,224$298.0K0.00%
Marshall Wace, LLP12,515$112.1K0.00%
Rhumbline Advisers275$2.46K0.00%
FMR LLC125$1.12K0.00%
Northwestern Mutual Wealth Management Co3$270.00%
Legacy Investment Solutions, LLC3$250.00%
Legacy Wealth Managment, LLC3$250.00%

Sold out (3)

Institutions that held Precision Biosciences Inc at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of DTIL in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Redwood Wealth Management Group, LLC15,378$149.6K
Toth Financial Advisory Corp100$973
Qube Research & Technologies Ltd8$78

Not filed for Q3 2024 yet (1)

Institutions that held Precision Biosciences Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DTIL in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.52,848$514.2K